We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Allergy Therapeutics Plc | LSE:AGY | London | Ordinary Share | GB00B02LCQ05 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.00 | 2.80 | 3.20 | 3.00 | 3.00 | 3.00 | 32,599 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 59.59M | -43.07M | -0.0090 | -3.33 | 142.99M |
Date | Subject | Author | Discuss |
---|---|---|---|
03/11/2017 11:08 | Jimmy, Are you able to post Panmure statement or a link to it | richsawko | |
03/11/2017 10:09 | Ewanwhose et al, Panmure have issued an exceptional research note on AGY. The price target is 53p including 12p of USA though they add with the portfolio and multiple news catalysts that 'anything could happen' DYOR | jimmyloser | |
01/11/2017 09:26 | Looks like a nice spot to buy for the next leg up. So I have. | volsung | |
01/11/2017 08:09 | I would say that now is less risky than the past as the pipeline has advanced successfully. Going forward my be cautious but potential rewards outstanding | richsawko | |
31/10/2017 22:50 | Just got some spare cash after several years. Was in these a long time ago but the story still seems as it was.Still like the concept but is there any reason to get now? | ewanwhose | |
24/10/2017 15:21 | There is smoke here today and you know what they say...impo. | jimmyloser | |
24/10/2017 11:24 | There's always another buying opp. They're like buses. | volsung | |
24/10/2017 11:08 | Buying opportunity gone! | audigger | |
23/10/2017 08:08 | Whilst they may need cash in the future, I'm not seeing the need to raise any now. It does raise the interesting question as to what price would a rights issue be at? | audigger | |
22/10/2017 09:44 | 3335 - you bet! That wasn't the market impo, it was just a correction caused by panic amongst small fry. It was frothy. impo/dyor | jimmyloser | |
22/10/2017 09:37 | AuDigger & volsung - or the market sees a rights issue coming if the special resolutions are passed at next month's AGM? | b1lbo | |
20/10/2017 15:45 | certainly looks that way | volsung | |
20/10/2017 15:43 | Strange that its taken such a big hit today. Buying opportunity! | audigger | |
13/10/2017 10:30 | Would love to think this is now going to go after so many years, but hey, we've been here before! | aruntim | |
13/10/2017 08:17 | Well bought some more this morning | volsung | |
12/10/2017 19:15 | I'd be happy to sell at 100p in 3-4years time. I originally bought at 7p and sold almost immediately at 14p on news that the clinical hold was lifted. Since then I have bought at 14p, 18p, 25p and 32p. I have a paper profit but see this as a medium term play that should come to fruition if they are successful,in the USA. Thereafter their novel adjuvant systems and potential to address peanut allergy represents further potential upside. And.....one should not forget the EU business which continues to grow market share. That's why I'm thinking beyond 60p. Knowing at what point to sell when you're in profit is one of the hardest investment decisions! | audigger | |
12/10/2017 16:48 | That was a long time ago. I don't like to tempt fate! | jimmyloser | |
12/10/2017 16:32 | If you weren't called jimmyloser I'd be encouraged by that post | volsung | |
12/10/2017 16:30 | It has surprised me on the upside. I have this to be 35p by year end in my forecast. It has murdered that. I would say that the dynamics at play here are >That the market is starting to forget the American setback. >The strength of performance with added consistency. > The strategy and management have credibility > The portfolio is strong and coming to fruition is some cases. >They are 100% on a charm offensive SOLID/RELIABLE AND WITH HUGE UPSIDE POTENTIAL impo/dyor I am now seeking 55p by the end of next year. Fingers crossed. | jimmyloser | |
12/10/2017 16:08 | I've had this stock since 2009, we've always said it was a slow burn, I don't think I realised how slow. I have a sell set from 60p in small parcels up to 90p, what others thoughts on this? | aruntim | |
12/10/2017 16:01 | Non-exec buying shares | aruntim | |
10/10/2017 19:19 | We appear to have a breakout situation! The company are spreading the word and people are waking up to the potential. | audigger | |
10/10/2017 06:46 | Today’s RNS released by AGY featuring Hardman and Cos paper would be a good reason. Not showing above in News re RNS as I post. Company sponsored but very positive appraisal. | friendzarin | |
09/10/2017 16:00 | wow - this is going well. Any thoughts as to why this is flying? | stefanj26 | |
09/10/2017 14:29 | See Link to slides from Thursday nights presentation given by Nick Wykeman (CFO) I made a few brief notes (mainly from the Q&As) so I will endeavor to write those up this evening | timbo003 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions